跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 462 条关于
“rMDD”
全部
462
临床试验
426
药物
18
机构
4
资讯
14
去年
Combination Therapy Shows Promise in Slowing Cognitive Decline in High-Risk Adults
去年
Predicting Response to rTMS: Early Symptom Improvement Key in Depression Treatment
去年
HMNC Brain Health Completes Patient Randomization in Phase 2b Trial of BH-200 for Major Depressive Disorder
去年
Xenon Pharmaceuticals Advances Azetukalner Program for Epilepsy and MDD
去年
Alto Neuroscience's ALTO-100 Fails Phase 2b Trial for Major Depressive Disorder
17天前
Adjunctive Lumateperone Improves Sexual Function in MDD Patients With Inadequate Antidepressant Response
去年
Relmada Therapeutics Announces Positive Progress in MDD and Metabolic Disease Programs
去年
Relmada Therapeutics Anticipates Key Interim Analysis for REL-1017 in MDD
去年
Intra-Cellular Therapies Seeks FDA Approval for Caplyta as Adjunctive MDD Treatment
去年
FDA Grants Breakthrough Device Designations for Novel Neuromodulation Therapies Targeting PTSD and MDD
第 1 页,共 2 页
上一页
下一页